Aurobindo Pharma, a mid-size pharmaceutical company, witnessed a rise in share price on Monday after it announced that the company has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Injection.
Shares of the company are trading at Rs 1,304.10, up Rs 56.4, or 4.52% at the Bombay Stock Exchange (BSE) on Monday at 11:15 a.m.
The scrip has touched an intra-day high of Rs 1,305 and low of Rs 1,262.05. The total volume of shares traded at the BSE is 84,158.